OrganoClick AB (DE:0CF)
FRANKFURT:0CF
Want to see DE:0CF full AI Analyst Report?
0CF Stock Chart & Stats
€0.13
€0.00(0.00%)
At close: 4:00 PM EST
€0.13
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.01 - €0.21
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€7.10M
Enterprise Value€158.49M
Total Cash (Recent Filing)€2.68M
Total Debt (Recent Filing)€77.78M
Price to Earnings (P/E)―
Beta-0.24
Next Earnings
May 06, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding110,003,010
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€11.42M
Bulls Say, Bears Say
Bulls Say
Sustainable Bio-based Product PlatformOrganoClick’s core technology targets substitution of fossil-based chemistries across textiles and wood. That product-driven, sustainability-oriented model aligns with durable regulatory and customer trends toward greener inputs, creating structural demand and differentiation over months.
Gross Margin Improvement Vs 2022An observed gross margin improvement versus 2022 suggests the company can improve product economics through either cost control, formulation gains, or pricing power. Sustained margin improvement is a necessary foundation for path to profitability as revenues scale or stabilize.
Diversified B2B Product Mix And Lean HeadcountSelling functional chemicals for textiles, wood solutions plus branded products spreads commercial exposure across end markets. A small workforce (40 employees) implies a lean cost base and operational agility, which can help preserve runway while commercial adoption progresses.
Bears Say
Persistent And Widening LossesThe company has been loss-making with net margin deteriorating to roughly -34% in 2025 and widening operating losses. Persistent negative profitability impairs internal funding capacity, increases reliance on external capital, and raises risk that operational issues are structural rather than temporary.
Material Increase In LeverageLeverage spiked sharply as equity contracted and debt climbed, leaving debt-to-equity near 6.4x. That capital-structure shift materially reduces financial flexibility, heightens refinancing and covenant risk, and constrains the company’s ability to invest in commercialization or absorb shocks.
Negative Operating And Free Cash FlowOperating cash flow swung negative in 2025 and free cash flow has been negative consistently. Continued cash burn forces dependence on external financing, which can dilute shareholders or be unavailable, limiting the company’s ability to scale manufacturing, sales, or R&D over the medium term.
OrganoClick AB News
0CF FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was €0.01 and its highest was €0.21 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is €7.10M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is May 06, 2026 which is in 11 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on Feb 12, 2026. The company reported -€0.009 earnings per share for the quarter, missing the consensus estimate of -€0.006 by -€0.003.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate is >-0.01.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 110,003,010 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -€0.009 in its last earnings report, missing expectations of -€0.006. Following the earnings report the stock price went up 1.6%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in DE:0CF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a material and chemical technology company, develops, produces, and markets fiber-based materials and chemicals for treatment of wood, technical textile and nonwoven, and bio composites in Sweden. It offers OrganoWood, a wood preservative technology and wood preservative that gives wood enhanced durability against rot and fire primarily for construction companies and consumers; OrganoTex, a biodegradable durable water repellent technology and textile treatment that makes textile products water repellent, as well as offers shoe and clothes care products; and OrganoComp, a biobased plastic-free and degradable bio-composite used for making 3D-shaped objects that replaces hard plastic materials. The company also provides consumer products, including a range of maintenance and cleaning products for wood, facades, roofs, and terraces, as well as for car care under the BIOkleen name; OC-BioBinder, a biobased, plastic-free, and degradable binder used by industrial customers as a replacement for plastic binders in nonwoven and technical textiles; and OC-AquaSil Tex, a biodegradable hydrophobing product used to replace PFAS in nonwovens, specialty papers, and technical textiles. The company was founded in 2006 and is headquartered in Täby, Sweden.
Technical Analysis
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Impact Coatings AB
―
XP Chemistries AB
―